Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Date:12/11/2012

ase (BTK). BTK is a key mediator of at least three critical B-cell pro-survival mechanisms occurring in parallel – regulating B-cell apoptosis, cell adhesion, and lymphocyte migration and homing. Data are consistent with a mechanistic model whereby ibrutinib blocks BCR signaling, which drives cells into apoptosis and/or disrupts cell migration and adherence to tumor-protective microenvironments.

The effectiveness of ibrutinib alone or in combination with other treatments is being studied in several B-cell malignancies, including chronic lymphocytic leukemia/small lymphocytic lymphoma, relapsed/refractory mantle cell lymphoma, diffuse large B-cell lymphoma, follicular lymphoma and multiple myeloma. A comprehensive late-stage Phase 2 and 3 program is under way.

Conference Call and Webcast Details

Pharmacyclics will be holding a conference call on Wednesday, December 12, 2012 at 8:30 AM ET. To participate in the conference call, please dial 1-877-407-0778 for domestic callers and 1-201-689-8565 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's website at www.pharmacyclics.com.

About the Pharmacyclics and Janssen Collaboration

Pharmacyclics, Inc. and Janssen Biotech, Inc. entered into a worldwide collaboration on December 8, 2011, to develop and commercialize ibrutinib. Following regulatory approval, Pharmacyclics and Janssen will co-commercialize ibrutinib. Each company will lead development for specific indications as stipulated in a global development plan.

About Pharmacyclics

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innov
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
6. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
9. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
10. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that it ... Food and Drug Administration ("FDA") verifying that the Company ... the warning letter it received from the FDA in ... re-inspection in March 2015 by the FDA at CryoLife,s ...
(Date:4/27/2015)...   AMC Health , a leading provider of ... care that are transforming chronic care and population health ... May 2-5 at the Los Angeles ... information about how their innovative programs, solutions and services ... healthcare delivery at Booth #2116 and during their joint ...
(Date:4/27/2015)... April 27, 2015 Harwood Feffer LLP ( ... of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the ... has breached its fiduciary duties to shareholders. ... release announcing results from its first Phase 3 registration ... disclosed that in the trial, Rhopressa failed to meet ...
Breaking Medicine Technology:CryoLife Announces Resolution of FDA Warning Letter 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2
... NORTH WALES, Pa., Feb. 16, 2011 AirPal, a ... received notification of allowance from the U.S. Patent Office ... position patients for situations such as difficult airway management, ... The company, founded in 1982, now holds more than ...
... and Willkie Farr & Gallagher will host an anti-bribery ... trends on French companies operating internationally. The seminar will ... of Willkie Farr & Gallagher. Please visit www.traceinternational.org ... event or contact king@traceinternational.org French ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2TRACE and Willkie Farr Announce Anti-Bribery Seminar in Paris 2
(Date:4/27/2015)... 27, 2015 "Understanding Mental Disorders: Your ... 1 by American Psychiatric Publishing, a division of the ... 1pm at the National Press Club in Washington, D.C.. ... moderated by APA President Paul Summergrad, MD. Guest speakers ... the foreword to the book; Paul Gionfriddo, President and ...
(Date:4/27/2015)... Md. (PRWEB) April 27, 2015 On May ... ones will ask their social media friends around the world ... dismissed as asthma. , May 5 is World Pulmonary ... (PHA), a leader in the global PH community, will take ... or high blood pressure of the lungs. PH is an ...
(Date:4/27/2015)... According to a recent report from NIDCR ... back pain, TMJ disorders are the second most ... In addition, the report revealed that TMJ disorders affect ... an estimated 4 billion dollars annually. , These estimates ... unrelated symptoms such as headaches, neck pain, tenderness of ...
(Date:4/27/2015)... As ISO 27001 has quickly become the ... all sizes and in all industries, Pivot Point Security ... ISO 27001 certification. The information security audit firm has ... ISO 27001 certification. Pivot Point's commitment to ISO 27001 ... of Lead Implementers and Auditors the company employs (now ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Guided by ... field of patient experience and its collaboration with organizations ... The Beryl Institute identifies eight essential actions ... The Beryl Institute believes organizations and systems committed to ... Identify and support accountable leadership with committed time ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2
... breakdown of retinoic acid, derived from vitamin A, is ... models of human prostate cancer, say investigators from the ... of the agent VN/14-1 resulted in up to a ... with human prostate cancer cells, reported Aakanksha Khandelwal, Ph.D., ...
... Study Supported Efficacy, Safety and Tolerability of ... 13-17 with Schizophrenia -, TOKYO and PRINCETON, ... Bristol-Myers Squibb Company (NYSE: BMY ) announced ... approved the supplemental New,Drug Application for the atypical ...
... increase 21% over the ... FARMINGTON, Conn., Nov. 6 Darwin Professional,Underwriters, Inc. ("Darwin," the ... for the third quarter ended September 30,2007. Highlights include: -- ... Third quarter gross premiums written are 5.9% ...
... ARLINGTON, Va., Nov. 6 In ... Network,s, (http://www.HealthCentral.com ) MyDiabetesCentral.com has launched ... of those with diabetes and provides,important ... this condition. The,special section, which can ...
... 6 QED International Associates Inc.,administrator for the ... portfolios, today announced that effective at the,opening of ... Ltd.,(Nasdaq: GIVN ) will replace Dade Behring ... Diagnostics Index, and Inverness Medical Innovations,(Amex: IMA ...
... Toronto, ON (November 6, 2007) Canadian researchers expect to ... network of hundreds of thousands of people who volunteer their ... complex problems. , The research team, led by Dr. ... at Princess Margaret Hospital and University Health Network, are the ...
Cached Medicine News:Health News:Drug slows prostate tumor growth by keeping vitamin A active 2Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 2Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 3Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 4Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 5Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 6Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 7Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 8Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 7Health News:The HealthCentral Network's MyDiabetesCentral.com Promotes Awareness of Diabetes 2Health News:The HealthCentral Network's MyDiabetesCentral.com Promotes Awareness of Diabetes 3Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes 2Health News:IBM world community grid squeezes decades of cancer research into 2 years 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: